Figure S1. t-SNE plots for all subtypes in the TCGA cohort, showing: 1) luminal subtypes cluster relatively closely, with Basal cluster highly distant, 2) substantial admixture across subtypes as indicated by cases located near non-assigned centroids. (centroidsâ=âopen circles) (PPTX 2616 kb
Table S1. Overview of clinical characteristics of the patient and tumour information stratified by t...
Table S1. Patient characteristics. Table S2. Hazard ratios from multivariate analysis. Table S3. Seq...
Figure S4. Silhouette width of each sample and community in breast cancer for each reconciliation me...
Figure S2. t-SNE plots showing subtype clustering of Luminal A cases in the TCGA cohort according to...
Table S2. Clinical characteristics of patients in the TCGA cohort with Luminal A breast cancer, clas...
Table S3. Molecular characteristics of Luminal A breast cancers in the TCGA cohort classified by sub...
Table S1. Top ten genes ranked by differences in gene expression between Tertile 1 (pure) and Tertil...
P-values and statistics from analysis of variance identifying the top 500 pathway entities defining ...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Figure S3. Comparison of community classifications from each reconciliation method with intrinsic br...
Abstract Background PAM50 gene profiling assigns each cancer to a single intrinsic subtype. However,...
Six proteins differentially expressed between luminal A samples in COCA cluster 1 versus COCA cluste...
Table S1. Number of patients for breast cancer subtype in the TCGA dataset according to IHC status. ...
Refined subtype labels and intrinsic probes. The refined breast cancer subtype labels defined for ea...
Molecular annotation of external cohort in function of TNBC clusters and non-TNBC. Radar plot showin...
Table S1. Overview of clinical characteristics of the patient and tumour information stratified by t...
Table S1. Patient characteristics. Table S2. Hazard ratios from multivariate analysis. Table S3. Seq...
Figure S4. Silhouette width of each sample and community in breast cancer for each reconciliation me...
Figure S2. t-SNE plots showing subtype clustering of Luminal A cases in the TCGA cohort according to...
Table S2. Clinical characteristics of patients in the TCGA cohort with Luminal A breast cancer, clas...
Table S3. Molecular characteristics of Luminal A breast cancers in the TCGA cohort classified by sub...
Table S1. Top ten genes ranked by differences in gene expression between Tertile 1 (pure) and Tertil...
P-values and statistics from analysis of variance identifying the top 500 pathway entities defining ...
Figure S2. Gene Set Enrichment Analysis (GSEA) analysis between subtypes in breast cancer. (A-F) GSE...
Figure S3. Comparison of community classifications from each reconciliation method with intrinsic br...
Abstract Background PAM50 gene profiling assigns each cancer to a single intrinsic subtype. However,...
Six proteins differentially expressed between luminal A samples in COCA cluster 1 versus COCA cluste...
Table S1. Number of patients for breast cancer subtype in the TCGA dataset according to IHC status. ...
Refined subtype labels and intrinsic probes. The refined breast cancer subtype labels defined for ea...
Molecular annotation of external cohort in function of TNBC clusters and non-TNBC. Radar plot showin...
Table S1. Overview of clinical characteristics of the patient and tumour information stratified by t...
Table S1. Patient characteristics. Table S2. Hazard ratios from multivariate analysis. Table S3. Seq...
Figure S4. Silhouette width of each sample and community in breast cancer for each reconciliation me...